Wei Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wei Li has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
Qian Wang
Capital Normal University
18 shared publicationsShaoru Tang
8 shared publicationsXin Huang
Department of Chemistry, Capital Normal University, No. 105 West Third Ring Road North, Haidian District, Beijing 100048, People’s Republic of China
8 shared publicationsSen Luan
7 shared publicationsXiaojian Hou
7 shared publicationsYanan Ma
7 shared publications
Latest Publications
- 16 October 2026
- Published by American Chemical Society (ACS) in ACS Applied Energy Materials
- Vol. 9 (21) , 13884-13894
Fabrication of Multicavity Hierarchically Porous Carbon Nanospheres Using Compressed CO2 for Overall Water Splitting
The rational design of efficient bifunctional electrocatalysts is crucial for overall water splitting. As a catalyst support, the multicavity hierarchically porous carbon spheres scaffold facilitates efficient electron transport and structural stability during catalysis. Herein, we report a reverse microemulsion strategy assisted by supercritical/compressed CO2 for the synthesis of multicavity hierarchically porous carbon nanospheres. Pyrolysis of nickel phthalocyanine (NiPc) and dicyandiamide as nickel and nitrogen sources, respectively, yields nickel nanoparticles embedded in nitrogen-doped porous carbon nanospheres modified with atomically dispersed Ni sites (Ni–N@MC). The multicavity hierarchically porous structure affords abundant active sites and an enlarged interface, exhibiting low overpotentials of 197 mV for the oxygen evolution reaction (OER) and 148 mV for the hydrogen evolution reaction (HER) at 10 mA cm–2, thus demonstrating excellent bifunctional electrocatalytic activity. An overall water-splitting electrolyzer using this catalyst as both electrodes achieves 10 mA cm–2 at 1.59 V with over 24 h stability.
- 16 October 2026
- Published by American Chemical Society (ACS) in ACS Applied Energy Materials
- Vol. 9 (21) , 13884-13894
Fabrication of Multicavity Hierarchically Porous Carbon Nanospheres Using Compressed CO2 for Overall Water Splitting
The rational design of efficient bifunctional electrocatalysts is crucial for overall water splitting. As a catalyst support, the multicavity hierarchically porous carbon spheres scaffold facilitates efficient electron transport and structural stability during catalysis. Herein, we report a reverse microemulsion strategy assisted by supercritical/compressed CO2 for the synthesis of multicavity hierarchically porous carbon nanospheres. Pyrolysis of nickel phthalocyanine (NiPc) and dicyandiamide as nickel and nitrogen sources, respectively, yields nickel nanoparticles embedded in nitrogen-doped porous carbon nanospheres modified with atomically dispersed Ni sites (Ni–N@MC). The multicavity hierarchically porous structure affords abundant active sites and an enlarged interface, exhibiting low overpotentials of 197 mV for the oxygen evolution reaction (OER) and 148 mV for the hydrogen evolution reaction (HER) at 10 mA cm–2, thus demonstrating excellent bifunctional electrocatalytic activity. An overall water-splitting electrolyzer using this catalyst as both electrodes achieves 10 mA cm–2 at 1.59 V with over 24 h stability.
- Open Access
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Co-Pyrolysis-Induced 1D/3D Hierarchical Carbon Framework with Multimetallic Alloys and M–Nx Sites for Trifunctional Electrocatalysis
The development of a single non-noble-metal electrocatalyst that concurrently promotes the oxygen reduction reaction (ORR), oxygen evolution reaction (OER), and hydrogen evolution reaction (HER) is highly desirable yet remains a significant challenge. Herein, we report a precursorcoupled copyrolysis strategy to construct a hierarchical multifunctional catalyst (CNT@CNZIF) by coupling FeNi-C3N4 with trimetallic CuCoZn-ZIF. During pyrolysis, N-doped carbon nanotubes (CNTs) grow in situ on the ZIF-derived porous polyhedra, with -shellencapsulated multimetal alloy nanoparticles located at the nanotube tips, while atomically dispersed M–N4 sites are stabilized within the N-doped carbon framework and at the particle–carbon interfaces. XPS and XAS analyses confirm electronic coupling between the alloy domains and the heteroatomcoordinated metal centers. CNT@CNZIF delivers superior trifunctional activity with an ORR half-wave potential of 0.89 V and OER/HER overpotentials of 239/178 mV at 10 mA cm⁻2. As a Zn-air battery cathode, it achieves a peak power density (211.1 mW cm⁻2), specific capacity (815.1 mAh g⁻1), and specific energy (1033.8 Wh kg⁻1), with stable cycling over ~160 h. A symmetric electrolyzer using CNT@CNZIF for both electrodes requires only 1.68 V at 10 mA cm⁻2 and retains 96.7% of its initial current after 8 h at 1.65 V.
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCo-Pyrolysis-Induced 1D/3D Hierarchical Carbon Framework with Multimetallic Alloys and M–Nx Sites for Trifunctional Electrocatalysis
The development of a single non-noble-metal electrocatalyst that concurrently promotes the oxygen reduction reaction (ORR), oxygen evolution reaction (OER), and hydrogen evolution reaction (HER) is highly desirable yet remains a significant challenge. Herein, we report a precursorcoupled copyrolysis strategy to construct a hierarchical multifunctional catalyst (CNT@CNZIF) by coupling FeNi-C3N4 with trimetallic CuCoZn-ZIF. During pyrolysis, N-doped carbon nanotubes (CNTs) grow in situ on the ZIF-derived porous polyhedra, with -shellencapsulated multimetal alloy nanoparticles located at the nanotube tips, while atomically dispersed M–N4 sites are stabilized within the N-doped carbon framework and at the particle–carbon interfaces. XPS and XAS analyses confirm electronic coupling between the alloy domains and the heteroatomcoordinated metal centers. CNT@CNZIF delivers superior trifunctional activity with an ORR half-wave potential of 0.89 V and OER/HER overpotentials of 239/178 mV at 10 mA cm⁻2. As a Zn-air battery cathode, it achieves a peak power density (211.1 mW cm⁻2), specific capacity (815.1 mAh g⁻1), and specific energy (1033.8 Wh kg⁻1), with stable cycling over ~160 h. A symmetric electrolyzer using CNT@CNZIF for both electrodes requires only 1.68 V at 10 mA cm⁻2 and retains 96.7% of its initial current after 8 h at 1.65 V.
- Open Access
- 22 April 2026
- Published by IMR Press in ALPHA PSYCHIATRY
- Vol. 27 (2)
Efficacy and Safety of Risperidone Microspheres for Injection (II) in Patients With Schizophrenia Spectrum Disorders: A Prospective, Single-Arm, Multicenter Real-World Study
Background: Long-acting injectable (LAI) antipsychotics improve adherence and promote long-term recovery in schizophrenia spectrum disorders (SSD). Risperidone Microspheres for Injection (II) (RMI-II), a novel LAI formulation, offers rapid symptom control with a 2-week dosing interval. However, real-world evidence regarding its efficacy and safety remains limited. Methods: A prospective, single-arm, multicenter study was conducted across 15 Chinese research centers. Eligible patients (n = 228) met DSM-5 criteria for SSD, had a Positive and Negative Syndrome Scale (PANSS) total score ≥70, and were followed for 12 weeks. Patients received RMI-II (25–50 mg/2 weeks) via intramuscular injection. Results: Among 228 patients (50.88% male, mean age [37.00 ± 12.82] years) receiving RMI-II, the PANSS total score decreased significantly by 14.02 (3.22, 24.85) at week 2 (p < 0.001) and 38.28 (19.02, 51.34) at week 12 (p < 0.001). At week 2, 37.1% patients achieved clinical response (defined as ≥20% reduction in PANSS total score), and this proportion increased to 83.7% by week 12. By the end of the 12-week treatment, the clinical remission rate (defined as scores ≤3 on PANSS items P1, P2, P3, N1, N4, N6, G5, and G9) was 68.9%. The Clinical Global Impression–Severity Scale score improved from a baseline moderate-to-severe level 5.0 (5.0, 6.0) to a mild-to-moderate level 3.0 (2.0, 4.0). Adverse events occurred in 15.35% of patients, with hyperprolactinemia (1.3%) and extrapyramidal symptoms (1.3%) being most common. Conclusions: RMI-II appeared to be effective and well-tolerated in reducing acute psychotic symptoms. These findings suggest it may represent an additional therapeutic option for SSD. Clinical Trial Registration: No: ChiCTR2200066865, 20 December 2022, https://www.chictr.org.cn/showproj.html?proj=183302.
- 22 April 2026
- Published by IMR Press in ALPHA PSYCHIATRY
- Vol. 27 (2)
Open AccessEfficacy and Safety of Risperidone Microspheres for Injection (II) in Patients With Schizophrenia Spectrum Disorders: A Prospective, Single-Arm, Multicenter Real-World Study
Background: Long-acting injectable (LAI) antipsychotics improve adherence and promote long-term recovery in schizophrenia spectrum disorders (SSD). Risperidone Microspheres for Injection (II) (RMI-II), a novel LAI formulation, offers rapid symptom control with a 2-week dosing interval. However, real-world evidence regarding its efficacy and safety remains limited. Methods: A prospective, single-arm, multicenter study was conducted across 15 Chinese research centers. Eligible patients (n = 228) met DSM-5 criteria for SSD, had a Positive and Negative Syndrome Scale (PANSS) total score ≥70, and were followed for 12 weeks. Patients received RMI-II (25–50 mg/2 weeks) via intramuscular injection. Results: Among 228 patients (50.88% male, mean age [37.00 ± 12.82] years) receiving RMI-II, the PANSS total score decreased significantly by 14.02 (3.22, 24.85) at week 2 (p < 0.001) and 38.28 (19.02, 51.34) at week 12 (p < 0.001). At week 2, 37.1% patients achieved clinical response (defined as ≥20% reduction in PANSS total score), and this proportion increased to 83.7% by week 12. By the end of the 12-week treatment, the clinical remission rate (defined as scores ≤3 on PANSS items P1, P2, P3, N1, N4, N6, G5, and G9) was 68.9%. The Clinical Global Impression–Severity Scale score improved from a baseline moderate-to-severe level 5.0 (5.0, 6.0) to a mild-to-moderate level 3.0 (2.0, 4.0). Adverse events occurred in 15.35% of patients, with hyperprolactinemia (1.3%) and extrapyramidal symptoms (1.3%) being most common. Conclusions: RMI-II appeared to be effective and well-tolerated in reducing acute psychotic symptoms. These findings suggest it may represent an additional therapeutic option for SSD. Clinical Trial Registration: No: ChiCTR2200066865, 20 December 2022, https://www.chictr.org.cn/showproj.html?proj=183302.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
Unveiling the synergy of oxygen vacancies and built-in electric fields in thermally induced high-entropy heterojunctions for oxygen evolution electrocatalysis
Vertically aligned 2D/2D HEO/MoS 2 heterojunction with oxygen vacancies and strong built-in electric field activates lattice oxygen mechanism, enabling OH⁻ replenishment, self-regeneration, superior OER activity and stability.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
Unveiling the synergy of oxygen vacancies and built-in electric fields in thermally induced high-entropy heterojunctions for oxygen evolution electrocatalysis
Vertically aligned 2D/2D HEO/MoS 2 heterojunction with oxygen vacancies and strong built-in electric field activates lattice oxygen mechanism, enabling OH⁻ replenishment, self-regeneration, superior OER activity and stability.
- Open Access
- 5 October 2025
- Published by Juan José López-Ibor Foundation in Actas Españolas de Psiquiatría
- Vol. 53 (5) , 1040-1052
Network Analysis and Mediation Effect Analysis of Anxiety Symptoms and Sleep Patterns for Adolescents
Background: The escalating prevalence of mental health issues and sleep disturbances among Chinese adolescents has become a pressing public health concern. Despite increasing recognition of this issue, there remains a paucity of research elucidating the intricate interplay between anxiety symptoms and sleep patterns. To address this critical gap, this study employs advanced network analysis to explore the complex relationships between these two domains, offering novel insights into their interconnectedness. Methods: We conducted a large-scale, online, cross-sectional survey encompassing 48,074 adolescents. Anxiety symptoms were assessed using the Generalised Anxiety Disorder Scale-7 (GAD-7), while sleep quality was evaluated via the Pittsburgh Sleep Quality Index (PSQI). Daytime sleepiness and fatigue symptoms were measured using the Chinese Adolescent Daytime Sleepiness Scale and the Fatigue Symptom Scale (FSS). Demographic data were analysed using chi-square tests, and continuous variables were examined via t-tests. To investigate symptom-level relationships, we employed network and mediation effect analysis, providing a robust methodological framework. Results: Our findings reveal a concerning prevalence of anxiety and insomnia symptoms among adolescents, at rates of 32.1% and 39.9%, respectively. Adolescents exhibiting anxiety symptoms reported significantly higher levels of insomnia, fatigue, and daytime sleepiness. Mediation effect analysis uncovered a chain mediation pathway, whereby insomnia and fatigue symptoms sequentially mediated the relationship between anxiety and daytime sleepiness. Network analysis further identified GAD2 (uncontrollable worry) and PSQI7 (daytime function) as pivotal core symptoms, with FSS (fatigue symptoms) demonstrating the highest expected impact within the network. Conclusions: This study underscores the persistent severity of anxiety and sleep pattern disturbances among adolescents. These findings highlight the importance of addressing core symptoms—particularly GAD2 and PSQI7—in therapeutic interventions. The results provide a solid foundation for developing more effective, symptom-specific strategies to improve adolescent mental health and sleep quality.
- 5 October 2025
- Published by Juan José López-Ibor Foundation in Actas Españolas de Psiquiatría
- Vol. 53 (5) , 1040-1052
Open AccessNetwork Analysis and Mediation Effect Analysis of Anxiety Symptoms and Sleep Patterns for Adolescents
Background: The escalating prevalence of mental health issues and sleep disturbances among Chinese adolescents has become a pressing public health concern. Despite increasing recognition of this issue, there remains a paucity of research elucidating the intricate interplay between anxiety symptoms and sleep patterns. To address this critical gap, this study employs advanced network analysis to explore the complex relationships between these two domains, offering novel insights into their interconnectedness. Methods: We conducted a large-scale, online, cross-sectional survey encompassing 48,074 adolescents. Anxiety symptoms were assessed using the Generalised Anxiety Disorder Scale-7 (GAD-7), while sleep quality was evaluated via the Pittsburgh Sleep Quality Index (PSQI). Daytime sleepiness and fatigue symptoms were measured using the Chinese Adolescent Daytime Sleepiness Scale and the Fatigue Symptom Scale (FSS). Demographic data were analysed using chi-square tests, and continuous variables were examined via t-tests. To investigate symptom-level relationships, we employed network and mediation effect analysis, providing a robust methodological framework. Results: Our findings reveal a concerning prevalence of anxiety and insomnia symptoms among adolescents, at rates of 32.1% and 39.9%, respectively. Adolescents exhibiting anxiety symptoms reported significantly higher levels of insomnia, fatigue, and daytime sleepiness. Mediation effect analysis uncovered a chain mediation pathway, whereby insomnia and fatigue symptoms sequentially mediated the relationship between anxiety and daytime sleepiness. Network analysis further identified GAD2 (uncontrollable worry) and PSQI7 (daytime function) as pivotal core symptoms, with FSS (fatigue symptoms) demonstrating the highest expected impact within the network. Conclusions: This study underscores the persistent severity of anxiety and sleep pattern disturbances among adolescents. These findings highlight the importance of addressing core symptoms—particularly GAD2 and PSQI7—in therapeutic interventions. The results provide a solid foundation for developing more effective, symptom-specific strategies to improve adolescent mental health and sleep quality.
- Open Access
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 7376934
The Deteriorated Center‐Surround Suppression in Patients With First‐Episode and Drug‐Naïve Major Depressive Disorder
Background: Major depressive disorder (MDD) patients are often associated with inhibition deficits in the visual cortex. Most previous research has focused on visual inhibition in MDD patients during acute and remission phases, with little research on first‐episode and drug‐naïve (FEDN) patients. To fill this gap, we psychophysically investigated the inhibitory process of visual motion in patients with FEDN MDD. Methods: Two psychophysical tasks: Center‐Surround Suppression (CSS) and Motion Repulsion (MR) were utilized to investigate the presence of visual perceptual inhibition deficits in patients with FEDN MDD. We collected data from 74 patients with FEDN MDD and 68 healthy controls (HCs) matched for age, years of education, and gender. We also measured the Hamilton Depression Rating Scale, 17‐item (HAMD‐17) for each patient to assess the severity of depressive symptoms. Results: The results showed that CSS was significantly deteriorated in FEDN MDD patients ( p = 0.001), but it did not correlate with the HAMD score ( p > 0.05). In addition, no significant differences were observed between the two groups of subjects in terms of gender, age, and education level (all p > 0.05). Analysis of two previously published datasets using the same CSS task involving MDD patients in different illness stages revealed that the levels of CSS reduction in our FEDN patients were also significantly distinguishable from those in acute and recovered MDD patients (all p < 0.01). This quantitative comparison indicates that CSS impairments are dynamic over the course of illness development. Moreover, the magnitudes of MR showed no significant differences between MDD patients and HCs (all p > 0.05). Conclusions: Our study was the first to demonstrate the deteriorated CSS in patients with FEDN MDD. Notably, inhibitory deficits in MDD are also highly specific, as MDD affects only the CSS, but not the MR. Therefore, the discrepancy between these two psychophysical tasks suggests CSS may serve as a feasible early marker in MDD. These findings offer new insights into the specific visual cortical deficits in patients with FEDN MDD. Limitation: The current study lacks imaging data to support the perceptual phenomenon we observed.
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1) , 7376934
Open AccessThe Deteriorated Center‐Surround Suppression in Patients With First‐Episode and Drug‐Naïve Major Depressive Disorder
Background: Major depressive disorder (MDD) patients are often associated with inhibition deficits in the visual cortex. Most previous research has focused on visual inhibition in MDD patients during acute and remission phases, with little research on first‐episode and drug‐naïve (FEDN) patients. To fill this gap, we psychophysically investigated the inhibitory process of visual motion in patients with FEDN MDD. Methods: Two psychophysical tasks: Center‐Surround Suppression (CSS) and Motion Repulsion (MR) were utilized to investigate the presence of visual perceptual inhibition deficits in patients with FEDN MDD. We collected data from 74 patients with FEDN MDD and 68 healthy controls (HCs) matched for age, years of education, and gender. We also measured the Hamilton Depression Rating Scale, 17‐item (HAMD‐17) for each patient to assess the severity of depressive symptoms. Results: The results showed that CSS was significantly deteriorated in FEDN MDD patients ( p = 0.001), but it did not correlate with the HAMD score ( p > 0.05). In addition, no significant differences were observed between the two groups of subjects in terms of gender, age, and education level (all p > 0.05). Analysis of two previously published datasets using the same CSS task involving MDD patients in different illness stages revealed that the levels of CSS reduction in our FEDN patients were also significantly distinguishable from those in acute and recovered MDD patients (all p < 0.01). This quantitative comparison indicates that CSS impairments are dynamic over the course of illness development. Moreover, the magnitudes of MR showed no significant differences between MDD patients and HCs (all p > 0.05). Conclusions: Our study was the first to demonstrate the deteriorated CSS in patients with FEDN MDD. Notably, inhibitory deficits in MDD are also highly specific, as MDD affects only the CSS, but not the MR. Therefore, the discrepancy between these two psychophysical tasks suggests CSS may serve as a feasible early marker in MDD. These findings offer new insights into the specific visual cortical deficits in patients with FEDN MDD. Limitation: The current study lacks imaging data to support the perceptual phenomenon we observed.
- 10 October 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (42) , 15553-15568
Qualitative and Quantitative Changes of Oligosaccharides in Human and Animal Milk over Lactation
The aim of this study was to investigate the changes in human and animal milk oligosaccharides over lactation. In total, 89, 97, 115, and 71 oligosaccharides were identified in human, bovine, goat, and camel milk. The number of common oligosaccharides between camel and human milk was the highest (16 and 17 in transitional and mature milk). With respect to the absolute concentration of eight oligosaccharides (2'-FL, 3-FL, α3'-GL, LNT, LNnT, 3'-SL, 6'-SL, and DSL), 2'-FL, 3'-FL, LNT, and LNnT were much higher in human than three animal species. 3'-SL had a similar concentration in bovine colostrum (322.2 μg/mL) and human colostrum (321.0 μg/mL), followed by goat colostrum (105.1 μg/mL); however, it had the highest concentration in camel mature milk (304.5 μg/mL). The ratio of 6'-SL and 3'-SL (1.77) in goat colostrum was similar to that in human colostrum (1.68), followed by bovine colostrum (0.13). In terms of changes of eight oligosaccharides over lactation, they all decreased with the increase of lactation in bovine and goat milk; however, α3'-GL, 2'-FL, and 3-FL increased in camel species, and LNT increased first and then decreased over lactation in human milk. This study provides a better understanding of the variation of milk oligosaccharides related to lactation and species.
- 10 October 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (42) , 15553-15568
Qualitative and Quantitative Changes of Oligosaccharides in Human and Animal Milk over Lactation
The aim of this study was to investigate the changes in human and animal milk oligosaccharides over lactation. In total, 89, 97, 115, and 71 oligosaccharides were identified in human, bovine, goat, and camel milk. The number of common oligosaccharides between camel and human milk was the highest (16 and 17 in transitional and mature milk). With respect to the absolute concentration of eight oligosaccharides (2'-FL, 3-FL, α3'-GL, LNT, LNnT, 3'-SL, 6'-SL, and DSL), 2'-FL, 3'-FL, LNT, and LNnT were much higher in human than three animal species. 3'-SL had a similar concentration in bovine colostrum (322.2 μg/mL) and human colostrum (321.0 μg/mL), followed by goat colostrum (105.1 μg/mL); however, it had the highest concentration in camel mature milk (304.5 μg/mL). The ratio of 6'-SL and 3'-SL (1.77) in goat colostrum was similar to that in human colostrum (1.68), followed by bovine colostrum (0.13). In terms of changes of eight oligosaccharides over lactation, they all decreased with the increase of lactation in bovine and goat milk; however, α3'-GL, 2'-FL, and 3-FL increased in camel species, and LNT increased first and then decreased over lactation in human milk. This study provides a better understanding of the variation of milk oligosaccharides related to lactation and species.
- 12 June 2023
- Published by Elsevier in Food Chemistry
- Vol. 426, 136615
The preparation of Diacylglycerol-rich soybean oil by acetylated modification of arachin nanoparticles for W/O Pickering emulsion system
- 12 June 2023
- Published by Elsevier in Food Chemistry
- Vol. 426, 136615
The preparation of Diacylglycerol-rich soybean oil by acetylated modification of arachin nanoparticles for W/O Pickering emulsion system